Whittier Trust Co. of Nevada Inc. lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.6% in the first quarter, HoldingsChannel reports. The fund owned 126,463 shares of the exchange traded fund’s stock after buying an additional 4,378 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in SPDR S&P Biotech ETF were worth $16,288,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the business. Financial Life Planners purchased a new position in SPDR S&P Biotech ETF in the 1st quarter worth $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $30,000. SHP Wealth Management bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $31,000. Finally, Legacy Wealth Managment LLC ID bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $32,000.
SPDR S&P Biotech ETF Stock Performance
XBI opened at $160.46 on Monday. The company has a market cap of $10.85 billion, a P/E ratio of 11.47 and a beta of 0.82. The business’s 50-day moving average price is $137.41 and its 200-day moving average price is $130.02. SPDR S&P Biotech ETF has a 12 month low of $83.02 and a 12 month high of $160.82.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under Pressure
- This Under-the-Radar Industrial Is Quietly Powering AI
- Why Microsoft Looks Like the Best Big Tech Trade for H2 2026
- Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
